<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20">
 <label>20.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hoffmann</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Kleine-Weber</surname>
    <given-names>H</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Schroeder</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title>. 
  <source>Cell</source>
  <volume>181</volume>(
  <issue>2</issue>), 
  <fpage>271</fpage>–
  <lpage>280.e8</lpage> (
  <year>2020</year>). 
  <pub-id pub-id-type="pmid">32142651</pub-id>
 </mixed-citation>
 <note>
  <p>•• This is a fundamental study on viral entry essential to designing an antiviral and understanding the underlying biology of the novel virus.</p>
 </note>
</ref>
